EUVIMEDEUVIMED entdecken
Crossref

Trisindoline 5 Compound Inhibits Human Breast Cancer Stem Cell Formation by Downregulating the BCL-2 Gene Expression

Muhammad Fatoni, Yofinta I Salsabila, Awik P.D. Nurhayati, Shabrina Syifa Ghaissani, Mardi Santoso, Fahimah Martak

International Journal of Cell and Biomedical Science · 2022

DOI: 10.59278/cbs.v1i2.19 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cell and Biomedical Science, 2022. Verfasst von Muhammad Fatoni und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer cell's growth and survival are supported by breast cancer stem cells (bCSCs) mammosphere formation. bCSCs represent a subpopulation of undifferentiated cancer cells which associated with self-renewing abilities, tumor initiation, drug resistance, and metastasis. Overexpression of the B Cell Lymphoma 2 (BCL-2) family in many tumor cells contributes to apoptosis resistance. Trisindoline is an indole trimer alkaloid natural compound that provides a cytotoxic effect on cancer cells. A new modification of trisindoline has been synthesized into trisindoline 5 in 2021.

Objective

This study purposed to investigate the effect of trisindoline 5 compounds against BCL-2 gene expression in bCSCs in vitro.

Methods

The bCSCs MDA-MB-231 were divided into control and treatment groups which were further analyzed in gene expression using the qPCR Livak method.

Results

Based on gene expression analysis, the results showed that trisindoline 5 may decrease the expression of BCL-2 in MDA-MB-231 cells.

Conclusion

This study concludes that trisindoline 5 could downregulate the antiapoptotic BCL-2 gene expression in bCSCs in vitro.

Zitieren

APA

Fatoni, M., Salsabila, Y. I., Nurhayati, A. P., Ghaissani, S. S., Santoso, M., & Martak, F. (2022). Trisindoline 5 Compound Inhibits Human Breast Cancer Stem Cell Formation by Downregulating the BCL-2 Gene Expression. International Journal of Cell and Biomedical Science. https://doi.org/10.59278/cbs.v1i2.19

Vancouver

Fatoni M, Salsabila YI, Nurhayati AP, Ghaissani SS, Santoso M, Martak F. Trisindoline 5 Compound Inhibits Human Breast Cancer Stem Cell Formation by Downregulating the BCL-2 Gene Expression. International Journal of Cell and Biomedical Science. 2022. doi:10.59278/cbs.v1i2.19

BibTeX
@article{Fatoni2022,
  author = {Fatoni, Muhammad and Salsabila, Yofinta I and Nurhayati, Awik P.D. and Ghaissani, Shabrina Syifa and Santoso, Mardi and Martak, Fahimah},
  title = {Trisindoline 5 Compound Inhibits Human Breast Cancer Stem Cell Formation by Downregulating the BCL-2 Gene Expression},
  journal = {International Journal of Cell and Biomedical Science},
  year = {2022},
  doi = {10.59278/cbs.v1i2.19}
}
Kostenlos starten →